Perspective Therapeutics Inc (AMEX: CATX) on Monday, plunged -7.04% from the previous trading day, before settling in for the closing price of $3.55. Within the past 52 weeks, CATX’s price has moved between $2.70 and $19.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 49.34%. With a float of $48.92 million, this company’s outstanding shares have now reached $67.56 million.
In an organization with 119 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 100.0%, operating margin of -15937.09%, and the pretax margin is -13973.89%.
Perspective Therapeutics Inc (CATX) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Perspective Therapeutics Inc is 27.62%, while institutional ownership is 75.78%. The most recent insider transaction that took place on Dec 04 ’24, was worth 100,004. In this transaction Director of this company bought 25,975 shares at a rate of $3.85, taking the stock ownership to the 25,975 shares. Before that another transaction happened on Dec 04 ’24, when Company’s CEO bought 8,000 for $3.77, making the entire transaction worth $30,132. This insider now owns 36,257 shares in total.
Perspective Therapeutics Inc (CATX) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 49.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.82% during the next five years compared to -7.69% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Perspective Therapeutics Inc (CATX) is currently performing well based on its current performance indicators. A quick ratio of 9.60 was reported for the most recent quarter.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.84 million. That was inferior than the volume of 1.12 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 29.31%. Additionally, its Average True Range was 0.34.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 4.41%, which indicates a significant decrease from 22.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.61% in the past 14 days, which was lower than the 140.24% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.63, while its 200-day Moving Average is $10.92. However, in the short run, Perspective Therapeutics Inc’s stock first resistance to watch stands at $3.45. Second resistance stands at $3.59. The third major resistance level sits at $3.71. If the price goes on to break the first support level at $3.19, it is likely to go to the next support level at $3.07. Assuming the price breaks the second support level, the third support level stands at $2.93.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
Market capitalization of the company is 223.04 million based on 67,588K outstanding shares. Right now, sales total 1,430 K and income totals -46,510 K. The company made 370 K in profit during its latest quarter, and -15,120 K in sales during its previous quarter.
